DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Medical School
  3. HMS Scholarly Articles
  4. Discordance between clinical and immunological ART eligibility criteria for children in Malawi

Discordance between clinical and immunological ART eligibility criteria for children in Malawi

Open/View files
4247202.pdf (535.04 KB)
Date
2014
Author(s)
O’Hare, Bernadette
Newberry, Laura
Pelani, Isaac
Malisita, Ken
DOI
10.1186/1756-0500-7-666
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
O’Hare, Bernadette, Danny A Milner, Laura Newberry, Isaac Pelani, and Ken Malisita. 2014. “Discordance between clinical and immunological ART eligibility criteria for children in Malawi.” BMC Research Notes 7 (1): 666. doi:10.1186/1756-0500-7-666. http://dx.doi.org/10.1186/1756-0500-7-666.
Abstract
Background: Since May 2014, all HIV positive children aged less than five years in Malawi are eligible for ART. For children older than five years they are eligible if they are in WHO stage III/IV, if stage I/II, if their CD4 < 500 cells/mm3. Our goal was to compare the WHO clinical classification criteria (WHO stage + CD4/age) to CD4 count (CD4/age) on all children. Prior to 2014, children aged 2–5 years in stage I and II were eligible for ART if their CD4 was < 750 cells/mm3. We were interested in the increase in numbers of children in this age group who now meet the eligibility criteria and their average CD4 count. Methods: Data including age, stage and CD4 count were used. We examined the effect of using two different criteria; WHO staging and checking CD4 count if stage I or II versus CD4 count on all, on the numbers of children eligibility for ART in a cohort of 969 children aged 0 to 14 years in Blantyre, Malawi. Results: Using WHO stage + CD4/age, 786 patients out of 969 would have been treated and 183 would not. Using CD4/age, 745 patients out of 969 would have been treated and 224 would not. Within the 224 patients not treated by CD4 classification, 41 were clinical stage III or IV. The most common staging condition in these 41 children was low weight for age (i.e. underweight). 41% of children age2-5 years have a CD4 count >750. Conclusion: Most children are correctly started on treatment using recent guidelines. 41% more children <5 years will be started on ART.
Other Available Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247202/pdf/
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454650
Subjects

HIV treatment

Pediatrics

Africa

Malawi

CD4 count

WHO clinical staging

Collection
HMS Scholarly Articles
Mapped collections
SPH Scholarly Articles
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.